MIV 710 / Medivir - LARVOL DELTA

A Study to Evaluate Safety and Tolerability of MIV-711 in Osteoarthritis Patients (clinicaltrials.gov) - P2; N=50; Active, not recruiting; Sponsor: Medivir; Recruiting ➔ Active, not recruiting; N=80 ➔ 50

Enrollment change • Enrollment closed • Biosimilar • CNS Disorders • Demo Pain • Immunology • Inflammation • Osteoarthritis • Pain